Ergothioneine-focused Company, Jinsan Bio, Recieves RMB 60M Funding

Currently, the company focuses on the ergothioneine and committed to become the ergothioneine B-end raw materials leading enterprises.

---

Recently, Jiangsu Jinsan Bio-technology Co., Ltd (hereinafter referred to as: Jinsan Bio) announced the completion of RMB 60 million ($8.35 million) in angel round financing. The investor is CITIC INVESTMENT HOLDINGS. This is also the first time that Jinsan Bio has received investment since its establishment.

According to the National Enterprise Credit Information Publicity System, Jinsan Bio was founded on September 15, 2021, with a registered capital of RMB 10 million ($1.4 million). Its business scope includes bio-feed research and development, food sales (only sales of pre-packaged food), cosmetic retailing, and cosmetic wholesaling.

According to public information, Jinsan Bio is a synthetic biopharmaceutical raw material developer. The products are mainly oriented to the domestic and international health and beauty market, to meet the raw material needs of dietary supplements and other health products brands and functional skincare brands. Currently, the company focuses on the ergothioneine and committed to become the ergothioneine B-end raw materials leading enterprises.

It is understood that ergothioneine is a compound discovered in 1909, initially found in the fungus Claviceps purpurea. As a natural antioxidant, ergothioneine with excellent anti-aging efficacy has been applied to all kinds of cosmetics, including Estee Lauder Revitalizing Supreme+, Nutritious Super-Pomegranate, Ultimate Lift Regenerating Youth Eye Creme. Various products of La Mer, Clinique exist ergothioneine.